Biofrontera (BFRI) Finished Goods (2024 - 2026)
Biofrontera (BFRI) posted quarterly Finished Goods of $1.4 million for Q4 2025, down 78.54% year-over-year from $6.6 million in Q4 2024, and down 78.54% quarter-over-quarter from $6.6 million in Q4 2024.
Biofrontera (BFRI) Finished Goods (2024 - 2026) Analysis & Trends
Biofrontera's Finished Goods history runs 2 years deep, the most recent figure standing at $1.4 million for Q4 2025.
- In Q4 2025, Finished Goods fell 78.54% year-over-year to $1.4 million; the TTM figure through Dec 2025 stood at $1.4 million (down 78.54% YoY), while the FY2025 annual figure was $1.4 million, down 78.54% from the prior year.
- Finished Goods for Q4 2025 stood at $1.4 million, down from $6.6 million in the prior quarter.
- The five-year high for Finished Goods was $6.6 million in Q4 2024, with the low at $1.4 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.40 Bn | 43.44 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.69 Bn | 40.03 Bn | 2.15 Bn |
| 3 | Zoetis | 32.50 Bn | 30.83 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.10 Bn | 19.44 Bn | 683.80 Mn |
| 6 | Viatris | 18.92 Bn | 18.03 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.47 Bn | 15.08 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.99 Bn | 11.46 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - |
| 10 | Biofrontera | 19.26 Mn | 14.55 Mn | 9.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 862,000.00 |
| Dec 31, 2025 | 1.43 Mn |
| Dec 31, 2024 | 6.65 Mn |